13F HOLDINGS REPORT
Lynx1 Capital Management LP
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001892688-24-000144
Total Value
$282.2M
Positions
18
Other Managers
1
Confidential Omitted
No
Holdings (18)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MERUS N V | N5749R100 | 1,793,866 | $89.6M | 31.75% |
| 2 | STOKE THERAPEUTICS INC | STOK | 5,187,191 | $63.8M | 22.59% |
| 3 | C4 THERAPEUTICS INC | CCCC | 6,880,527 | $39.2M | 13.90% |
| 4 | GH RESEARCH PLC | GHRS | 4,195,894 | $28.1M | 9.95% |
| 5 | TSCAN THERAPEUTICS INC | TCRX | 5,224,600 | $26.0M | 9.22% |
| 6 | ALLOGENE THERAPEUTICS INC | ALLO | 6,202,374 | $17.4M | 6.15% |
| 7 | CULLINAN THERAPEUTICS INC | CGEM | 410,830 | $6.9M | 2.44% |
| 8 | PASSAGE BIO INC | PASG | 8,426,955 | $5.9M | 2.09% |
| 9 | IBIO INC | IBIO | 862,279 | $1.9M | 0.68% |
| 10 | CARIBOU BIOSCIENCES INC | CRBU | 680,189 | $1.3M | 0.47% |
| 11 | KODIAK SCIENCES INC | KOD | 271,177 | $707,772 | 0.25% |
| 12 | PIERIS PHARMACEUTICALS INC | 720795202 | 37,436 | $620,689 | 0.22% |
| 13 | CENTESSA PHARMACEUTICALS PLC | CNTA | 17,400 | $278,226 | 0.10% |
| 14 | BIONOMICS LIMITED | 09063M205 | 549,673 | $241,471 | 0.09% |
| 15 | KINIKSA PHARMACEUTICALS INTL | G52694109 | 8,231 | $205,693 | 0.07% |
| 16 | TENAX THERAPEUTICS INC | TENX | 14,751 | $51,038 | 0.02% |
| 17 | CENTURY THERAPEUTICS INC | IPSC | 19,028 | $32,538 | 0.01% |
| 18 | VYNE THERAPEUTICS INC | VYNE | 16,194 | $30,445 | 0.01% |